Literature DB >> 1651300

Differences in tetranectin immunoreactivity between benign and malignant breast tissue.

L Christensen1, I Clemmensen.   

Abstract

Tetranectin (TN) is a human, plasminogen kringle 4 binding plasma protein with ubiquitous cellular distribution and lectin-like characteristics. By means of the peroxidase-antiperoxidase staining technique a polyclonal and a monoclonal antibody were used to demonstrate TN within the intracellular as well as the extracellular compartment of invasive breast carcinoma. Whereas cell associated TN was universal showing only quantitative differences depending of the growth pattern of the tumor, 78 of 133 tumors displayed TN extracellularly as well. The occurrence of this stromal TN immunoreactivity was closely associated with desmoplasia, recognized morphologically by an increase in fibroblastic cells and immunohistochemically by an intense staining for the connective tissue glycoprotein fibronectin (FN). Benign breast tissue displayed a universal, intense cytoplasmic but no extracellular reaction for TN, with the exception of rare foci of granulation tissue and around dilated cysts. Functional studies have shown that human embryonal lung fibroblasts increase their release of TN to the growth medium upon stimulation. The presence of TN extracellularly within fibroblast-rich foci of desmoplasia (and granulation tissue) suggests that a similar increased release of the protein takes place in vivo during active states. Desmoplasia has been found to have a protective effect on tumor cell propagation and metastasis in a murine model. The molecular interactions, which are responsible for this effect, are undoubtedly complex. However, TN may, by its specific binding to kringle 4 of plasminogen and its high affinity for sulphated polysaccharides, add to the understanding of how plasminogen activation is modulated at the local extracellular level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651300     DOI: 10.1007/bf00315737

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  27 in total

1.  Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice.

Authors:  S H Barsky; R Gopalakrishna
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

2.  Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1989

3.  Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.

Authors:  I Clemmensen; L C Petersen; C Kluft
Journal:  Eur J Biochem       Date:  1986-04-15

4.  Different molecular forms of fibronectin in rheumatoid synovial fluid.

Authors:  I Clemmensen; R B Andersen
Journal:  Arthritis Rheum       Date:  1982-01

5.  Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues.

Authors:  L Christensen; N Johansen; B A Jensen; I Clemmensen
Journal:  Histochemistry       Date:  1987

6.  Increased content of Type V Collagen in desmoplasia of human breast carcinoma.

Authors:  S H Barsky; C N Rao; G R Grotendorst; L A Liotta
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

7.  Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein.

Authors:  J Fuhlendorff; I Clemmensen; S Magnusson
Journal:  Biochemistry       Date:  1987-10-20       Impact factor: 3.162

8.  Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.

Authors:  E M Salonen; O Saksela; T Vartio; A Vaheri; L S Nielsen; J Zeuthen
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins.

Authors:  R Lagacé; J A Grimaud; W Schürch; T A Seemayer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix.

Authors:  S Saunders; M Bernfield
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

View more
  11 in total

1.  Tetranectin, a trimeric plasminogen-binding C-type lectin.

Authors:  T L Holtet; J H Graversen; I Clemmensen; H C Thøgersen; M Etzerodt
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

2.  Tetranectin in slow intra- and extrafusal chicken muscle fibers.

Authors:  X Xu; B Gilpin; K Iba; A Maier; E Engvall; R Albrechtsen; U M Wewer
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

3.  Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer.

Authors:  A Brunner; C Ensinger; M Christiansen; S Heiss; I Verdorfer; G Mikuz; A Tzankov
Journal:  Virchows Arch       Date:  2007-04-13       Impact factor: 4.064

4.  The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain.

Authors:  R H Lorentsen; J H Graversen; N R Caterer; H C Thogersen; M Etzerodt
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

5.  Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity.

Authors:  K Iba; M E Durkin; L Johnsen; E Hunziker; K Damgaard-Pedersen; H Zhang; E Engvall; R Albrechtsen; U M Wewer
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Identification of tetranectin as a potential biomarker for metastatic oral cancer.

Authors:  Martha E Arellano-Garcia; Roger Li; Xiaojun Liu; Yongming Xie; Xiaofei Yan; Joseph A Loo; Shen Hu
Journal:  Int J Mol Sci       Date:  2010-09-02       Impact factor: 5.923

7.  Mouse tetranectin: cDNA sequence, tissue-specific expression, and chromosomal mapping.

Authors:  K Ibaraki; C A Kozak; U M Wewer; R Albrechtsen; M F Young
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

8.  Aberrant tetranectin expression in human breast carcinomas as a predictor of survival.

Authors:  P Obrist; G Spizzo; C Ensinger; D Fong; T Brunhuber; G Schäfer; M Varga; R Margreiter; A Amberger; G Gastl; M Christiansen
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

9.  A potential role for tetranectin in mineralization during osteogenesis.

Authors:  U M Wewer; K Ibaraki; P Schjørring; M E Durkin; M F Young; R Albrechtsen
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity.

Authors:  Tirsit Mogues; Michael Etzerodt; Crystal Hall; Georg Engelich; Jonas H. Graversen; Kevan L. Hartshorn
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.